EFPIA Japan Chief Frets Negative Market Growth amid Pressure on Drug Costs

EFPIA Japan Chairman Carsten Brunn Medium and long-term policies being weighed by the Japanese government to rein in drug spending would lead to negative growth in the country’s pharmaceutical market, EFPIA Japan Chairman Carsten Brunn warned on June 10. EFPIA...read more